Lisa Walters-Hoffert insider trades: Kiora Pharmaceuticals (KPRX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Lisa reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 19, 2024 | KPRX | ↑ Buy | 1,250 | $3.86 | $5K | Direct | Aug 20, 2024 (1d) |
| Apr 29, 2024 | FLUX | ↓ Sell | 534 | $4.50 | $2K | Direct | Apr 30, 2024 (1d) |
| Apr 22, 2024 | FLUX | ↓ Sell | 5,909 | $4.03 | $24K | Direct | Apr 22, 2024 (0d) |
| Sep 25, 2023 | FLUX | ↓ Sell | 6,761 | $3.88 | $26K | Direct | Sep 25, 2023 (0d) |
| Mar 7, 2023 | FLUX | ↑ Buy | 1,000 | $6.36 | $6K | Direct | Mar 8, 2023 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Lisa Walters-Hoffert's insider trades
Lisa Walters-Hoffert is a director at Kiora Pharmaceuticals (KPRX). Since Mar 7, 2023, Lisa has reported 2 open-market purchases worth $11K and 3 sales worth $52K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (16 filings), option exercises (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KPRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.